19-7152692-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000598216.1(INSR):​n.2240G>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0311 in 1,571,264 control chromosomes in the GnomAD database, including 7,858 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.043 ( 882 hom., cov: 31)
Exomes 𝑓: 0.030 ( 6976 hom. )

Consequence

INSR
ENST00000598216.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.403

Publications

10 publications found
Variant links:
Genes affected
INSR (HGNC:6091): (insulin receptor) This gene encodes a member of the receptor tyrosine kinase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form a heterotetrameric receptor. Binding of insulin or other ligands to this receptor activates the insulin signaling pathway, which regulates glucose uptake and release, as well as the synthesis and storage of carbohydrates, lipids and protein. Mutations in this gene underlie the inherited severe insulin resistance syndromes including type A insulin resistance syndrome, Donohue syndrome and Rabson-Mendenhall syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
INSR Gene-Disease associations (from GenCC):
  • insulin-resistance syndrome type A
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
  • Donohue syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
  • hyperinsulinism due to INSR deficiency
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, Ambry Genetics
  • Rabson-Mendenhall syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 19-7152692-C-T is Benign according to our data. Variant chr19-7152692-C-T is described in ClinVar as Benign. ClinVar VariationId is 1269775.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.472 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
INSRNM_000208.4 linkc.2231+34G>A intron_variant Intron 10 of 21 ENST00000302850.10 NP_000199.2 P06213-1
INSRNM_001079817.3 linkc.2231+34G>A intron_variant Intron 10 of 20 NP_001073285.1 P06213-2
INSRXM_011527988.3 linkc.2231+34G>A intron_variant Intron 10 of 21 XP_011526290.2
INSRXM_011527989.4 linkc.2231+34G>A intron_variant Intron 10 of 20 XP_011526291.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
INSRENST00000598216.1 linkn.2240G>A non_coding_transcript_exon_variant Exon 10 of 10 1
INSRENST00000302850.10 linkc.2231+34G>A intron_variant Intron 10 of 21 1 NM_000208.4 ENSP00000303830.4 P06213-1
INSRENST00000341500.9 linkc.2231+34G>A intron_variant Intron 10 of 20 1 ENSP00000342838.4 P06213-2

Frequencies

GnomAD3 genomes
AF:
0.0428
AC:
6499
AN:
151976
Hom.:
878
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00495
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.166
Gnomad ASJ
AF:
0.00433
Gnomad EAS
AF:
0.488
Gnomad SAS
AF:
0.0558
Gnomad FIN
AF:
0.0602
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00393
Gnomad OTH
AF:
0.0326
GnomAD2 exomes
AF:
0.0837
AC:
20858
AN:
249218
AF XY:
0.0725
show subpopulations
Gnomad AFR exome
AF:
0.00381
Gnomad AMR exome
AF:
0.235
Gnomad ASJ exome
AF:
0.00785
Gnomad EAS exome
AF:
0.504
Gnomad FIN exome
AF:
0.0566
Gnomad NFE exome
AF:
0.00480
Gnomad OTH exome
AF:
0.0488
GnomAD4 exome
AF:
0.0299
AC:
42399
AN:
1419170
Hom.:
6976
Cov.:
26
AF XY:
0.0288
AC XY:
20411
AN XY:
708250
show subpopulations
African (AFR)
AF:
0.00316
AC:
103
AN:
32612
American (AMR)
AF:
0.224
AC:
9994
AN:
44656
Ashkenazi Jewish (ASJ)
AF:
0.00861
AC:
223
AN:
25900
East Asian (EAS)
AF:
0.515
AC:
20308
AN:
39464
South Asian (SAS)
AF:
0.0405
AC:
3455
AN:
85250
European-Finnish (FIN)
AF:
0.0561
AC:
2984
AN:
53204
Middle Eastern (MID)
AF:
0.00526
AC:
22
AN:
4184
European-Non Finnish (NFE)
AF:
0.00264
AC:
2835
AN:
1075000
Other (OTH)
AF:
0.0420
AC:
2475
AN:
58900
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
1681
3361
5042
6722
8403
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
490
980
1470
1960
2450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0428
AC:
6509
AN:
152094
Hom.:
882
Cov.:
31
AF XY:
0.0509
AC XY:
3784
AN XY:
74334
show subpopulations
African (AFR)
AF:
0.00496
AC:
206
AN:
41522
American (AMR)
AF:
0.167
AC:
2551
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
0.00433
AC:
15
AN:
3466
East Asian (EAS)
AF:
0.488
AC:
2498
AN:
5118
South Asian (SAS)
AF:
0.0550
AC:
265
AN:
4814
European-Finnish (FIN)
AF:
0.0602
AC:
638
AN:
10602
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00393
AC:
267
AN:
68000
Other (OTH)
AF:
0.0322
AC:
68
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
231
463
694
926
1157
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
68
136
204
272
340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0222
Hom.:
214
Bravo
AF:
0.0521
Asia WGS
AF:
0.219
AC:
758
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
1.6
DANN
Benign
0.78
PhyloP100
-0.40
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3745548; hg19: chr19-7152703; COSMIC: COSV57164517; API